Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA

Seeking AlphaJun 25 14:07 ET

Most Shareholders Will Probably Agree With Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) CEO Compensation

Key Insights Tarsus Pharmaceuticals' Annual General Meeting to take place on 13th of June Salary of US$619.5k is part of CEO Bobby Azamian's total remuneration The overall pay is 49% below the ind

Simply Wall StJun 7 06:09 ET

Tarsus to Participate in Upcoming Investor Conferences

IRVINE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,

GlobeNewswireMay 29 17:00 ET

12 Health Care Stocks Moving In Monday's Pre-Market Session

GainersTevogen Bio Holdings (NASDAQ:TVGN) stock rose 55.4% to $1.53 during Monday's pre-market session. The market value of their outstanding shares is at $251.8 million. MiNK Therapeutics (NASDAQ:INK

BenzingaMay 13 08:06 ET

Analysts Are Betting On Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) With A Big Upgrade This Week

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The analysts have sharply increased

Simply Wall StMay 13 06:27 ET

Express News | Tarsus Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $61 From $57

ReutersMay 13 05:59 ET